---
search:
  boost: 3
---

# Oral Acne Products

This is a subcategory of Dermatological Agents.

## Decision Trees

- [Dermatological Oral Acne Products- Non-Preferred Agents - Absorica, Absorica LD](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUQUZRNDdQRTdGWlFRREtBTDZEUTcyT1JSUSQlQCN0PWcu){ :target="_blank" rel="noopener"}

- [Dermatological Oral Acne Products- Preferred Agents - Accutane, Amnesteem, Claravis, Isotretinoin, Myorisan, Zenatane](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUN005SEUyNUVXNVhZVDFTTktQNU5ZWTFFTyQlQCN0PWcu){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                  | Generic Name | Quantity | Time (Days) |
| :------------------------- | :----------- | :------: | :---------: |
| Accutane <sup>PA</sup>     |              |          |             |
| Amnesteem <sup>PA</sup>    |              |          |             |
| Claravis <sup>PA</sup>     |              |          |             |
| Isotretinoin <sup>PA</sup> |              |          |             |
| Myorisan <sup>PA</sup>     |              |          |             |
| Zenatane <sup>PA</sup>     |              |          |             |

### Non-Preferred

| Non-Preferred | Generic Name | Quantity | Time (Days) |
| :------------ | :----------- | :------: | :---------: |
| Absorica      |              |          |             |
| Absorica LD   |              |          |             |

## Authorizations ([Process by GSN](https://special-spoon-f542dccd.pages.github.io/Clinical%20and%20Technical%20Reference%20Guide/PA%20-%20Standard%20of%20Work/HICL%20GCNSeqNo%20NDC/?h=hicl))

**Length of Authorizations**: 150 days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Clinical PA

Clinical PA Criteria

- Must have had an inadequate clinical response of at least ^^90 days^^ with at least ^^one preferred^^ topical **AND** ^^one preferred^^ oral antibiotic for acne
- Must be absent of oral tretinoin in the past 56 days
- Prescriber attests that patient is registered and meets all of the requirements of the iPLEDGE program

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least ^^90 days^^ with at least ^^two preferred^^ drugs
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Additional Information

- Authorization length will be for no more than 150 days at a time then must take 56 days off

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7BCD777F63-7F18-4713-8D6A-B043BEE631F5%7D&file=Denial%20Language%20Updated%2009112023.docx&action=embedview&mobileredirect=true&wdStartOn=44&cid=f4472ece-6d4f-4694-b0c5-c150a2f53fea){:target="_blank" rel="noopener"} </br>
[Criteria](https://medicaid.ohio.gov/static/PHM/drug-coverage/20231001+UPDL+Criteria+_v2.FINAL.pdf#page=50){ :target="_blank" rel="noopener"} </br>
[Preferred Drug List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20231001_UPDL_V2.FINAL.hyperlinks_added.pdf#page=19){ :target="_blank" rel="noopener"} </br>
[Quantity Limit List](https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/Quantity%20Limits.pdf){ :target="_blank" rel="noopener"}
